Statistics in Pharmaceutical Development and Manufacturing

descriptionPublicationkeyboard_double_arrow_right Article 01 Apr 2009 English Publisher:Informa UK LimitedJournal:Journal of Quality Technology, volume 41, pages 111-134 (issn: 0022-4065, eissn: 2575-6230,

Authors: Anthony J. Carella; J John; Peterson; Timothy L. Schoefield; Paul R. McCallister; Ronald D. Snee;

doi: 10.1080/00224065.2009.11917764

Statistics in Pharmaceutical Development and Manufacturing

- Summary
- Metrics

Abstract

An overview is given of the use of statistical thinking and methods in the research and development and manufacturing functions in the pharmaceutical industry. Four case studies illustrate how these issues work in real life settings. A synopsis of these..

Related Organizations

Pfizer (United States)
United States
GlaxoSmithKline (United Kingdom)
United Kingdom
Merck & Co.
United States
Cellzome, GSK, Middlesex, UK.

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	36
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%